Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014

Evans, Mary; Person, Marissa K; Reilley, Brigg; Leston, Jessica; Haverkate, Richard; McCollum, Jeffrey; Apostolou, Andria; Bohm, Michele K.; Handel, Michelle Van; Bixler, Danae; Mitsch, Andrew; Haberling, Dana L.; Hatcher, Sarah M.; Weiser, Thomas; Elmore, Kim; Teshale, Eyasu H.; Weidle, Paul J.; Peters, Philip J.

doi:10.1177/0033354920937284

Cited by 4 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indigenous people who use injection drugs (IPWIDs) experience elevated risks for both HCV infection and overdose, however little is known about substance use patterns that affect HCV risk within IPWIDs. In one study of Indian Health Services health care encounters, it was documented that 25.6% of adults aged 18-35 had concurrent diagnoses of HCV infection and opioid use disorder (OUD) [5]. This pilot study aimed to document patterns in polysubstance use across the lifespan among IPWIDs in a tribal community that experienced an influx of illicit substances due to the development of nearby oil drilling over the past decade.…”

Section: Introductionmentioning

confidence: 99%

A Pilot Study of Polysubstance Use Sequences across the Lifespan among Assiniboine and Sioux People Who Use Injection Drugs

Anastario

Firemoon

Rodriguez

et al. 2022

IJERPH

View full text Add to dashboard Cite

Compared with other racial/ethnic groups in the United States, American Indians/Alaska Natives have the highest rates of acute Hepatitis C Virus (HCV) infection, the highest HCV-related mortality, and one of the fastest climbing rates of drug overdose deaths involving stimulants. In this pilot study, a life history calendar was administered to Indigenous people who use injection drugs (IPWIDs) to understand sequences of polysubstance use across the lifespan. 40 IPWIDs completed a questionnaire and life history calendar. Social sequence analysis was used to examine patterns in sequential phenomena among substances reported over years of the lifespan. Most participants (55%) began injecting substances before the age of 21, 62.5% shared syringes with others, and 45% had ever been diagnosed with HCV. An appreciably large increase in the use of stimulants occurred between the year prior to and following injection initiation (33% to 82%). A three-cluster solution distinguished younger IPWIDs transitioning into polysubstance use involving stimulants and/or narcotic analgesics from adults using narcotic analgesics with stimulants over longer periods of time, and adults most focused on stimulant use over time. Findings from this pilot study contribute to an understanding of how methamphetamine injection plays a role in the HCV epidemic among IPWIDs.

show abstract

Section: Introductionmentioning

confidence: 99%